When Barb Ballard gave birth to her son Ray in 1994, doctors provided him with newborn screening. The screening revealed nothing unusual, and, at the time, Ballard considered the screening “a blessing of good genetic health.”
You are here
“SCID Compass: A Carrier’s Perspective,” is a discussion between four women affected by SCID, one of whom has SCID, and three mothers of children with SCID who are carriers of a SCID gene variant.
Mutations in genes of persons with chronic granulomatous disease (CGD) affect the person’s production of superoxide, which in turn dictates the severity of CGD symptoms.
A recently published research paper explores healthcare provider knowledge gaps pertaining to severe combined immunodeficiency (SCID).
While treatments for primary immunodeficiencies vary, proper nutrition, regular exercise, appropriate amounts of sleep, and stress reduction benefits people with all types of PI diagnoses.
Brothers Nicholas and Eric Mato, diagnosed with chronic granulomatous disease during their childhood, relied on interferon-gamma treatments and prophylactic medication to stay healthy and today are attending college and building their careers.
Duke University School of Medicine allergist/immunologist Dr. Rebecca Buckley used T cell-depleted bone marrow transplant (BMT) to save the lives of hundreds of infants with severe combined immunodeficiency (SCID).
Toddler Jakob Guziak is diagnosed with ADA-SCID and awaits treatment with gene therapy.
PBS Exploration Health examines the science of chronic granulomatous disease (CGD), profiles persons living with CGD, interviews doctors serving the CGD community, and explores the various treatment options available to families coping with the disease.
The FDA awarded a UCSF Artemis-SCID gene therapy clinical trial with a Regenerative Medicine Advanced Therapy (RMAT) designation, which means the FDA will help guide the development of the trial.